Risk factors associated with rectal carriage of extended spectrum beta-lactamases producing Enterobacterales among inpatients at a tertiary hospital in Northern Nigeria: A cross-sectional study Authors: Yahaya Yaqub, Yusuf Muhammed, Henry Gabriel Bishop, Zainab Rabilu Daninna, Elaija Ekah Ella, Zainab Lamido Tanko, Aliyu Aminu, Abubakar Jibril, Muhammad Sani Aliyu Published: 2026 ABSTRACT AbstractAntimicrobial resistance (AMR) is a major cause of morbidity and mortality. AMR is a global problem that disproportionately affects the low and middle-income countries (LMIC), and Extended Spectrum Beta-lactamases producing Enterobacterales (ESBL-PE) are an important contributor. This study was aimed at understanding what risk factors were associated with the rectal carriage of ESBL-PE before the recent COVID-19 epidemic. This was a cross-sectional study conducted in 2017 at a tertiary health facility in northern Nigeria. Risk factors of interest were investigated using an interviewer-administered questionnaire, and a rectal swab sample was collected for analysis. Multiple logistic regression analyses were done to appreciate what risk factors were associated with rectal ESBL-PE carriage. This study found a rectal ESBL-PE carriage of 87.5% (N = 168). Significant risk factors included length of hospital stay in the past year outside Nigeria (X2 = 14.3, p = 0.003), any form of antibiotic use outside Nigeria (X2 = 8.2, p = 0.004), and beta-lactam antibiotic use outside Nigeria (X2 = 8.2, p = 0.004). Previous hospital admission outside Nigeria was found to be a protective independent risk factor against rectal ESBL-PE carriage (OR = 0.065, CI 0.005–0.806, p = 0.004). Rectal ESBL-PE carriage was high during the pre-COVID era in the LMIC context. As the COVID pandemic era ensures, it will be necessary to appreciate what risk factors for the rectal carriage of CRE look like. This would enable LMIC policymakers to contextualize countermeasures to be effective in mitigating the problem of AMR.Keywords: Rectal ESBL-PE carriage, Antimicrobial resistance, Surveillance, COVID-19, Renewed hope, NigeriaSubject terms: Diseases, Health care, Medical research, Microbiology, Risk factors Introduction The Enterobacterales are indisputably one of the most incriminated culprits of human diseases, causing both community and hospital acquired diseases. With Enterobacterales being commensals of the gut, this site provides them with a haven and thus a transit route through the hospital and the community1–3. Production of enzymes that hydrolyse the antibiotic agent is the most frequently mechanism of resistance utilized by the Enterobacterales against the beta-lactam group of antibiotics. These enzymes collectively called the beta-lactamases have evolved into several classes of which the extended spectrum beta lactamases (ESBL) are clinically important4. The appearance of ESBL producing Enterobacterales (ESBL-PE) in 1983 was a very serious setback to the antibiotic choices available to clinicians5. This is due to the extent of resistance conferred by these enzymes which spare only a few antibiotic choices. The ESBL enzymes have long been discovered to be mainly on plasmids and transposons which makes them highly transferable among the Enterobacterales6. ESBL-PE are multidrug-resistant organisms (MDROs) as they usually harbour plasmids that additionally carry resistance genes against fluoroquinolones and aminoglycosides6,7. These MDROs were initially often associated with hospitalized patient and the hospital environment due to the constant interaction between these organisms and the regular usage of antibiotics in the hospital2,5,8. However, there have been reports of recovery of these MDRO’s from community sewages clearly depicting the intestinal origin of these organisms in addition to their already established hand carriage9–11. A study in Nigeria showed a high faecal carriage rate 63% (n= 72) of ESBL-PE in animals12. This could be a direct picture of the possibility of spread in our environment of these MDROs. It is also an established fact that the epidemiology of resistant pathogens differs from country to country13. Four (i.e. Escherichia coli, Klebsiella pneumonia, Salmonella spp and Shigellaspp) of the seven bacterial pathogens discussed in the 2014 global surveillance report on antimicrobial resistance were members of the Enterobacterales14. Infections by these MDROs have been associated with a long hospital stay, delay in initiation of appropriate therapy and increased medical bill15. The rise in the use of third generation cephalosporins (3rd Gen Ceph) has brought with it the problem of resistance to these antibiotics especially among the Enterobacterales. The exact magnitude of the problem of resistant Enterobacterales may be difficult to know in Nigeria however, Okesola and colleagues found the prevalence of ESBL-PE isolates to be 76.9% among clinical isolates16. There have also been reports of ESBL-PE isolates from clinical specimens from Lagos17,18, Ogun19, Ibadan16, Abuja20and Kano21. The CDC deemed it necessary for the first time in 2013 to set threat levels to infectious agents as “urgent”, “serious” and “concerning” in decreasing order of importance, which is not in keeping with the recognized classification for infectious agents of bioterrorism. This was in response to the recognized increase in incidence of these multidrug-resistant pathogens worldwide and ESBL-PE were designated the threat levels “urgent”22.This lead to the CDC recommending rectal swab surveillance to keep track of these MDROs23. The recent classification by the WHO in 2024 of resistance Enterobactorales to 3rd Gen Ceph clearly depicts the significance of this onging threat posed by the ESBL-PE24. There have been such studies from other third world countries like Argentina25, Pakistan26, Ethiopia27, Morocco1, Madagascar28and Cameroon29. It has been well established that asymptomatic gastrointestinal colonization by ESBL-PE is a prelude to infections associated with them30. A study from the southern Nigeria reported a faecal carriage rate of 15.5% (n= 114) for ESBL-PE31. Research on the rectal carriage of ESBL-PE in northern Nigeria is scarce. Therefore, the aim of this study was to assess “Risk factors associated with rectal carriage of extended-spectrum beta-lactamase-producing Enterobacterales among inpatients at a tertiary hospital in Northern Nigeria. A Cross-sectional Study”. To achieve this, the folowing objectives were undertaken: 1.To determine the prevalence of rectal carriage by ESBL-PE; 2.To determine the risk factors associated with rectal carriage by ESBL-PE; 3.To appreciate which risk factors are independently associated with rectal carriage by ESBL-PE all among hospitalized patients. It was the hope of the authors that this study will give some appreciation of the risk factors in our context that may be associated with carriage of ESBL-PE in the pre-COVID 19 pandemic period. The findings of this study could be used as a reference point to compare with similar researches in the post COVID − 19 pandemic era. Methodology Study area Ahmadu Bello University Teaching Hospital (ABUTH) Zaria, was the study site. ABUTH Zaria, is located in Kaduna state in the North-western region of Nigeria. The hospital is a tertiary health facility with about a thousand bed-capacity. As a referral health facility, it receive about 10,000 patients each year from all parts of the country. Study design This study was a cross-sectional study to investigate the risk factors associated with rectal ESBL-PE carriage among hospitalised patients at ABUTH Zaria. An interviewer administered questionnaire was employed which was then followed with the collection of rectal swab sample from participants in the following wards; (medical, surgical, paediatrics, gynaecology and oncology) and, Units (Intensive Care Unit (ICU) and Special Care Baby Unit (SCBU)). The collected rectal swab samples were processed at the medical microbiology laboratory of the health facility. Sample size calculation A cross-sectional sample size calculator on Epi Info™ 7 (USA) was utilized to arrive at 168 for the Kelsey’s method. This was achieved with the following parameters; power of 80%, two-sided confidence interval of 95% and expected outcome in the unexposed was 11% (from a recent similar study32. Inclusion criteria Patients admitted into the following wards: medical, surgical, paediatrics, gynaecology and oncology and units: ICU & SCBU. Exclusion criteria Colostomy or dialysis patients who were in the above categories were not recruited as well as those who were declined rectal swab sampling. Sampling technique The sample size of 168 was divided across the seven units equally leading to recruitment of twenty-four patients in each unit. Patients on odd numbered beds were recruited during the initial visit and subsequently new patients were enrolled if they were on odd numbered beds. This process continued until the sample size was reached. However, in the ICU which has only six beds, all patients were recruited due to the scarcity of patients but in a non-repetitive fashion. Ethical consideration Ethical approval was obtained from the Ahmadu Bello University Teaching Hospital, Zaria ethical committee before the commencement of the study (ABUTHZ/HREC/T20/2016). Also, a written informed consent (or assent from the caregivers of those under 18 years) was collected from all study participants. Data collection tools Questionnaire An interviewer administered questionnaire was utilized followed by collection of rectal swab on each of the consenting (or assenting) participant. The questionnaire was used to collect information on the thirty-three associated risk factors of interest. These risk factors were divided into four section i.e. (1) Demographic risk factors (e.g.sex, age, education, etc.); (2) Environmental risk factors (e.g. place of residence, toilet facility, living with animals, etc.); (3) Current hospital risk factors (ward, length of stay, antibiotic use, etc.); (4) Past hospital risk factors (e.g. Previous hospital admission in Nigeria within the past 1 year, Length of hospital stay in Nigeria within the past 1 year, Previous hospital admission outside Nigeria within the past 1 year, etc. (See supplemental table). The outcome of interest was the rectal carriage of ESBL-PE. Rectal swab collection and processing An Amies transport swab was labelled and used to collect rectal swab from all participants in this study. The rectal swab sample was collected, transported to the lab, then Gram negative bacterial isolation, screening and confirmation for ESBL-PE and molecular characterization were done as described by Yaqub et al.33 Patients’ recruitment and laboratory processing of rectal sab were done between January 2017 and November 2017. Data analysis Data from each participant was entered into and cleaned in Excel spreadsheet. Binary entries were coded as 1 = yes and 0 = no while ordinal categorical entries were coded as 1, 2, 3 etc. Continuous data (i.e. “age (days)” and “length of hospital stay”) were stratified appropriately into weeks while “age (years)” was stratified into decades i.e. 1–10, 11–20 etc. All statistical analyses were done in Stata 14 (StataCorp LP, College Station, USA). Two-sided p-values (≤ 0.05) and confidence intervals (CI) of 95% were used for significance testing in this study. Prevalence of ESBL-PE rectal carriage was determined for the study. A Pearson chi-square (X2) test (i.e. 2-sided value) was used to check for association between information on risk factors collected in the questionnaire and ESBL-PE rectal carriage (i.e. outcome). Odds ratio (OR) was calculated for risk factors with significant associations to access the strength and nature of the risk factor associations to ESBL-PE rectal carriage. Logistic regression analyses were conducted to control for the confounding effects of the significantly associated risk factors observed in this study. All p values in this study were two-sided and p ≤ 0.05 was considered significant. Confidence Intervals (CIs) were 95% and were only considered significant if they did not include the null figure (i.e. 0 for χ2 tests and 1 for OR) and not wide from the observed values. Results The prevalence for ESBL-PE rectal carriage among participants (N = 168) of this study was 87.5%. Most of the ESBL-PE isolates were E. coli (83%, N = 139). The remaining ESBL-PE were Klebsiella pneumoniae 15% (n = 25) and Enterobacter aerogenes 2% (n = 4). Descriptive epidemiology of risk factors for rectal ESBL-PE carriage Participants’ ages were in years and thus categorized into decades i.e. 1–10, 11–20, etc. and no increasing proportion was observed. For the SCBU participants however, the ages were categorized into 1st through 4th week of life and it appears that the proportion of EBLE-PE carriage increased with age (Table 1). Female participants were slightly more than males in this study and these females had a higher proportion for rectal ESBL-PE carriage. Participants from all parts of the country had similarly high proportions of ESBL-PE carriage (Table 2). Table 1Description of participants’ demographic factors to rectal ESBL-PE carriages.VariablesProportion for ESBL n (%)Age (SCBU in days)n=241st week5/7 (71.4)2nd week7/9 (77.7)3rd week6/6 (100)4th week2/2 (100)Age (others in years)n=1441–1019/22 (86.4)11–202/2 (100)21–3020/23 (87)31–4027/28 (96.4)41–5021/25 (84)51–6022/26 (84.6)61–7013/14 (92.9)71–803/4 (75)SexN=168Male59/71 (83.1)Female88/97 (90.7)TribeN=168Hausa83/96 (86.4)Igbo11/11 (100)Yoruba11/12 (91.7)Others42/49 (85.7)Marital statusN=168Single52/60 (86.6)Married90/103 (87.4)Widowed3/3 (100)Divorced2/2 (100)OccupationN=168Trader22/27 (81.5)Farmer104/119 (87.4)Civil Servant21/22 (95.5)Educational statusN=168None7/10 (70)Primary or Islamic13/14 (92.9)Secondary116/131 (88.6)Tertiary11/13 (84.6) Description of participants’ demographic factors to rectal ESBL-PE carriages. Table 2Description of participants’ environmental risk factors to rectal ESBL-PE carriages.VariablesProportion for ESBL n (%)Place of residenceN = 168Kaduna99/113 (87.6)Northwest States27/30 (90)Other northern States15/19 (78.9)Other parts of Nigeria6/6 (100)Type of residenceN = 168Individual house26/31 (83.8)Shared compound21/137 (88.3)Living with AnimalsN = 168Yes108/123 (87.8)No39/45 (86.7)Water sourceN = 168Well or spring90/103 (87.4)Public tap52/59 (88.1)Private borehole5/6 (83.3)Toilet facilityN = 168Shared with public110/124 (88.7)Open defecation16/19 (84.2)Private21/25 (84) Description of participants’ environmental risk factors to rectal ESBL-PE carriages. There was a high proportion of ESBL-PE carriage across all wards and units (all > 75%). There was also high proportion of ESBL-PE carriage across all the categories of the length of hospital stay (all > 80%) (Table 3). Those with a history of previous admission in Nigeria were similar in proportion to those with no such history 75% and 88.5% respectively. However all those who have had a history of admission outside Nigeria did not carry ESBL-PE (n = 3) (Table 4). Table 3Description of participants’ current hospital risk factors to rectal ESBL-PE carriages.VariablesProportion for ESBL n (%)WardsN = 168Medical21/24 (87.5)Surgical19/24 (79.2)Gynaecology22/24 (91.7)Oncology23/24 (95.9)ICU21/24 (87.5)Paediatrics21/24 (87.5)SCBU20/24 (83.3)Working diagnosisN = 168infectious142/163 (87.1)non-infectious diseases5/5 (100)Length of hospital stay(days)N = 1681 st week61/73 (83.6)2nd week41/44 (93.2)3rd week22/25 (88)4th week15/17 (88.2)5th week5/6 (83.3)6th week3/3 (100)Antibiotic useN = 168Yes168/168 (100)Beta-lactam useN = 168Yes168/168 (100)Other antibiotic useN = 168Yes136/154 (88.3)No11/14 (78.6) Description of participants’ current hospital risk factors to rectal ESBL-PE carriages. Table 4Description of participants’ past hospital risk factors to rectal ESBL-PE carriages.VariablesProportion for ESBL n (%)Previous hospital admission in Nigeria within the past 1 yearYes9/12 (75)No138/156 (88.5)Length of hospital stay in past year in NigeriaNone138/156 (88.5)1 week2/3 (66.7)2 weeks4/6 (66.7)3 weeks3/3 (100)Antibiotic use in NigeriaYes9/12 (75)No138/156 (88.5)Beta-lactam use in NigeriaYesn = 9/12 (75)Non = 138/156 (88.5)Other antibiotic use in NigeriaYesn = 9/11 (81.8)Non = 138/157 (87.9)Previous hospital admission outside Nigeria in the past 1 yearYesn = 1/3 (33.3)Non = 146/165 (88.4)Length of hospital stay in past year outside Nigeria (days)Nonen = 146/165 (88.4)14 daysn = 0/1 (0)22 daysn = 0/1 (0)27 daysn = 1/1 (100)Antibiotic use outsideYesn = 1/3 (33.3)Non = 146/165 (88.4)Beta-lactam use outsideYesn = 1/3 (33.3)Non = 146/165 (88.4)Other antibiotic use outsideYesn = 1/3 (33.3)Non = 146/165 (88.4) Description of participants’ past hospital risk factors to rectal ESBL-PE carriages. Risk factors associated with rectal ESBL-PE carriage It can be inferred that out of the 33 risk factors investigated in this study, only four risk factors were found to have objective associations with rectal ESBL-PE carriage. These include previous hospital admission outside Nigeria in the past year (X2 8.2, p = 0.004), the length of that stay while seeking hospital admission outside Nigeria (X2 14.3, p = 0.003), Use beta-lactam (X2 8.2, p = 0.004) or other antibiotics (X2 8.2, p = 0.004) outside Nigeria when seeking medical attention. Beyond these 4 risk factors listed above, other risk factors did not show any association (Table 5). Table 5Association between some risk factors and rectal ESBL-PE carriage.VariablesX2P valuePrevious hospital admission outside Nigeria in the past year8.20.004Previous hospital admission within Nigeria in the past year1.80.174Length of hospital stay in past year outside Nigeria14.30.003Length of hospital stay in Nigeria2. 90.720Antibiotic use outside Nigeria8.20.004Beta-lactam use outside Nigeria8.20.004Ward patient is admitted3.90.702Present working diagnosis0.80.391See full table of association in Supplemental Table. Association between some risk factors and rectal ESBL-PE carriage. See full table of association in Supplemental Table. Multiple regression analyses revealed the nature these significantly associated risk factors had on the rectal carriage of ESBL-PE. These analyses found that history of previous hospital admission outside Nigeria in the past year was found to be strongly protective (OR 0.065, CI 0.005–0.806, p = 0.004). The length of hospital stay outside Nigeria was also protectively associated with rectal ESBL-PE carriage (OR 0.83 CI 0.71–0.98, p = 0.02). Any form of antibiotic use outside Nigeria during such stay was protective as well (0.065, CI 0.005–0.806, p = 0.004) (Table 6). Table 6Independent risk factors for rectal ESBL-PE carriage after controlling for the other significant risk factors shown here.S/no for risk factorVariablesRisk factors adjusted forOdds RatioP valueCI1Previous hospital admission outside Nigeria in the past 1 year2,3&40.0650.0040.005–0.8062Length of hospital stay in past year outside Nigeria1,3&40.830.020.71–0.983Antibiotic use outside Nigeria1,2&40.0650.0040.005–0.8064Beta-lactam use outside Nigeria1,2&30.0650.0040.005–0.806 Independent risk factors for rectal ESBL-PE carriage after controlling for the other significant risk factors shown here. Discussion The rectal carriage rate for ESBL-PE of 87.5% (N = 168) was more than double that reported by an earlier study from Morocco of 43% (n= 77) which had a similar study design6. The prevalence of ESBL-PE from this study was statistically comparable with the Moroccan study, (X2 = 53, p < 0.0001). A 2024 study from Egypt revealed that the rectal carriage rate for ESBL-PE was around 60% (n = 4,528) which also corroborated the findings of this study (X2 = 51, p< 0.0001)34. It should be noted that this Egyptian study spanned from 2007 to 2023, thus included mostly the pre-COVID period which this study (i.e. 2017) was conducted. On the contrary, a 2025 post-COVID meta-analysis assessment looking at the burden of intestinal carriage rate for ESBL-producing E.coliaround the world found the prevalence to be about 25% for the African region35. Previous hospital admission outside Nigeria did have a strong association (X2 = 8.2, p = 0.004) on rectal ESBL-PE carriage (Table 5). A multiple logistic regression controlling for other significant risk factors (i.e. Length of hospital stay in past year outside Nigeria (X2 = 14.3, p = 0.003), Any form of antibiotic use outside Nigeria (X2 = 8.2, p = 0.004) and Beta-lactam antibiotic use outside Nigeria(X2 = 8.2, p = 0.004) revealed that previous hospital admission outside Nigeria is a protective independent risk factor for rectal ESBL-PE carriage (OR = 0.065, CI 0.005–0.806, p = 0.004) (Table 6). Also, there appeared to be an association with increasing length of hospital admission outside Nigeria (X2 = 14.3, p = 0.003) to rectal ESBL-PE carriage among the study participants (Table 5). Although multiple logistic regression to control for other significant factors as listed above reduced the strength of this association, the length of time a participant spent on hospital admission outside Nigeria in the preceding year was still a protective risk factor (OR = 0.83, CI 0.71–0.98, p = 0.02) (Table 6). Using any form of antibiotic (X2 = 8.2, p = 0.004 each), during this hospital stay abroad also appeared to have an association with rectal ESBL-PE carriage (Table 5). But upon control for the other factors, each of these factors yielded an independent protective effect against rectal ESBL-PE carriage (OR = 0.065, CI 0.005–0.806, p = 0.004 each) (Table 6). These findings are similar to those of a Dutch study in 2014 which showed that travel outside the country and antibiotic use during the travel were strongly associated with rectal colonization by ESBL-PE36. A more recent study also reported similar findings37. It was observed that a history of previous admission within Nigeria, how long the admission was or a history of any form of antibiotic use did not have any association with ESBL-PE carriage (X2 =1.8, p = 0.17; X2 =2.7 p = 0.26 and X2 =1.8, p = 0.17 respectively). This are similar to the findings of 2014 study from the Netherlands which reported no difference (p= 0.6) between the ESBL-PE carriage of those admitted from long term care facilities and those from home settings within the country38. A further analysis on the relationship of having a relative who sort for medical attention outside Nigeria (p = 0.556) and how long the relative stayed (p = 0.865) did not have any association with rectal ESBL-PE carriage among participants. However, the use of a beta-lactam seem to have an association with ESBL-PE carriage (p= 0.01) but not with other antibiotics (0.556) Kunzeli et al. also had a similar finding from their study39. Sex of the participant showed no significant association with ESBL-PE rectal carriage (X2 = 2.2, p = 0.14). Also, ages among neonates (X2 =2.5, p = 0.47) and other patients (X2 =3.9, p = 0.79) were not associated significantly with ESBL-PE rectal carriage in this study. This was similar to the observations of the Platteel et al.38 It should be acknowledged that gender as a variable in determining AMR acquisition or carriage has long been under explored as argued by Gautron et al.40 The education status, occupation, marital status, place of residence a participant lived in and length of hospital stay within Nigeria, all did not have any association with rectal ESBL-PE carriage in this study (See Supplemental Table). A 2022 study conducted in Ethiopia reported a similar observation of no significant association between ESBL-PE rectal carriage and these five factors37. Tribe (i.e. ethnicity) as well did not seem to affect either ESBL-PE rectal carriage (X2 = 2.0, p = 0.57). This was despite the observation that the highest frequency of ESBL-PE rectal carriage was found among those who identified as Igbo (100%, n= 11). A study from Singapore reported no association between ESBL-PE rectal carriage and ethnicity41. The nature of water source the participants used in their homes was not associated with rectal ESBL-PE carriage (X2 =0.1, p = 0.94) which in keeping with the report of Kuenzli et al.39 Having an animal within the compound was also not associated with rectal ESBL-PE carriage (X2 =0.03, p = 0.84) which was similar to the report by Platteel et al.38 This study found no association between the toilet facility present in the participants residence and rectal ESBL-PE carriage (X2 =0.6, p= 0.73) and this was different from the observation from a study in a similar setting but on pregnant women in Tanzania42. The recent commentary of the One-Health approach necessity in the African context futher consolidates the findings of this study in many ramification43. Conclusion The high ESBL-PE carriage from this study reveals the enormity of these MDROs in a tertiary hospital in Nigeria as well as the protective effect of seeking medical attention outside Nigeria on the rectal carriage of ESBL-PE. These are important considerations for policy makers as well as mangers of tertiary health facilities in low- and medium- income countries like Nigeria. The present administration of the Federal Republic of Nigeria through the National Health Sector Renewal Investment Initiative (NHSRII) which is part of the “Renewed Hope Agenda”, appears to have put in measures to revitalise the moribund health system in the country. Although the dividend of this 46 billion naira ($ 30 m) backed NHSRII is palpable at the primary health centres across the country, it will be important to integrate policies that put in measures to tackle AMR as a priority in this early stage44. An important limitation of this study is that the countries that the participants received medical attention was not determined and such country related difference in ESBL-PE carriage rate could not be inferred. However, as this study was conducted in the pre-COVID 19 period, it could serve as a reference to with for future similar studies. Importantly also, further studies would be necessary to appreciate what the nature of these risk factors are to ESBL-PE carriage in the post-COVID 19 period. Abbreviations Ahmadu Bello University Teaching Hospital Extended spectrum beta-lactamases producing Enterobacterales Low- and medium- income countries Coronavirus disease Antimicrobial resistance Intensive care unit Special care baby unit Centre for disease control and prevention Multidrug-resistance organisms World Health Organization Author contributions YY: Research idea, methodology, data collection and entry, and writing the manuscript draft, YM: Research idea and final review of the manuscript for submission as Corresponding/Senior author, HGB: Literature search and manuscript draft, ZRD: Literature search and manuscript draft, EEE: final review of the manuscript for submission as Corresponding/Senior author, ZLT: Data collection, literature search and manuscript draft, AA: Research idea, literature search, methodology and manuscript draft, AJ: Literature search and manuscript draft, MSA: final review of the manuscript for submission as Corresponding/Senior author. All authors reviewed the manuscript and agreed on the submission. Data availability The datasets used and analyzed during the current study are available from the corresponding author on reasonable request. Declarations Competing interests The authors declare no competing interests. Ethics approval and consent to participate Ethical approval in accordance with the Declaration of Helsinki was obtained from the Ahmadu Bello University Teaching Hospital, Zaria Research Ethics Committee (Approval number: ABUTHZ/HREC/T20/2016) in accordance with the Helsinki Declaration. Informed consent to participate in the study was obtained from the parents or legal guardians of participants below the age of 16 years. Informed consent to participate in the study was obtained from participants aged 16 years and above. Consent for publication A general informed written consent was taken from all the participants involved in this study, which includes permission for anonymous use of data for the purpose of publication. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Data Availability Statement The datasets used and analyzed during the current study are available from the corresponding author on reasonable request.